【24h】

Development of Microemulsion Containing Prednisolone

机译:含有泼尼松龙微乳液的研制

获取原文

摘要

Prednisolone, an anti-inflammatory drug with a very slight solubility (0.23 mg/mL at 25 ° C), high permeability and short biological half-life (2-4 h) in oral administration was selected as the candidate drug for sustained drug release. The aim of this research is to formulate and evaluate the stable formation of oil-in-water microemulsion for enhancing the solubility of the model drug. Microemulsion containing oleic acid as oil component, Tween 20 and P188 as main surfactant and co-surfactant at different ratios were evaluated. The microemulsion was characterized by stability test, particle size, clarity, conductivity and pH value. A stable system at nano size (11.6 and 12.3 nm) which possibly enhanced drug solubility with no drug aggregation.
机译:泼尼松,选择具有非常轻微的溶解度(25℃的0.23mg / ml)的抗炎药,口服给药中的高渗透性和短生物半衰期(2-4小时)作为持续药物释放的候选药物。该研究的目的是制定和评估稳定地形成油包水微乳液,以提高模型药物的溶解度。评价含有油酸作为油组分,吐温20和P188作为主要表面活性剂和不同比例的共表面活性剂的微乳液。微乳液的特征在于稳定性试验,粒度,透明度,导电性和pH值。纳米尺寸(11.6和12.3nm)的稳定系统,其可能增强药物溶解度,没有药物聚集。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号